Mangumpit, Max Kaiden .

HRN: 21-94-28  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/30/2025
CEFTRIAXONE 1G (VIAL)
07/30/2025
08/06/2025
IV
450mg
Q8
TYPHOID FEVER
Remove - Pending Acceptance
08/01/2025
CEFTRIAXONE 1G (VIAL)
08/01/2025
08/07/2025
IVT
1.3g
Q24
Typhoid Fever
Remove - Pending Acceptance
08/01/2025
AZITHROMYCIN 200MG/5ML, 15ML SUSPENSION (SUSP)
08/01/2025
08/07/2025
ORAL
3.5ml
OD
Typhoid Fever
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: